Development of a Benefit/Risk Assessment Tool for Breast Cancer Chemoprevention

被引：0
|
作者：
Freedman, Andrew N. [1 ]
Yu, Binbing [2 ]
Gail, Mitchell H. [1 ]
Costantino, Joseph P. [3 ]
Graubard, Barry I. [1 ]
Vogel, Victor G. [4 ]
Anderson, Garnet L. [5 ]
McCaskill-Stevens, Worta [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] NIA, Bethesda, MD 20892 USA
[3] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA
[4] Geisinger Hlth Syst, Danville, PA USA
[5] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2011年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
627
引用
下载
收藏
页码：S273 / S274
页数：2
相关论文
共 50 条
  • [1] Breast Cancer Risk Assessment and Chemoprevention: Results of a Survey
    Lauro, C. F.
    Kutner, J. S.
    Klein, C. E.
    Rabinovitch, R.
    Fisher, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S592 - S593
  • [2] Benefit/Risk Assessment for Breast Cancer Chemoprevention With Raloxifene or Tamoxifen for Women Age 50 Years or Older
    Freedman, Andrew N.
    Yu, Binbing
    Gail, Mitchell H.
    Costantino, Joseph P.
    Graubard, Barry I.
    Vogel, Victor G.
    Anderson, Garnet L.
    McCaskill-Stevens, Worta
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) : 2327 - 2333
  • [3] Assessing utility of breast cancer risk assessment tool in comparison to Tyrer-Cuzick model for determination of breast cancer risk and implications for chemoprevention
    Pederson, Holly J.
    Yanda, Courtney
    Kline, Michele
    Stephens, Marcellia
    Goraya, Shazia T.
    Grobmyer, Stephen R.
    Kattan, Michael W.
    CANCER RESEARCH, 2018, 78 (04)
  • [4] Breast cancer risk assessment tool
    Fox, GN
    JOURNAL OF FAMILY PRACTICE, 2000, 49 (06): : 578 - 579
  • [5] Correlation between risk benefit index and uptake of breast cancer chemoprevention.
    Sivasubramanian, Parijatham S.
    Crew, Katherine D.
    Kalinsky, Kevin
    Hershman, Dawn L.
    Maurer, Matthew A.
    Greenlee, Heather
    Reimers, Laura L.
    Terry, Mary Beth
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] RISK-BENEFIT INDEX OF TAMOXIFEN AND RALOXIFENE FOR CHEMOPREVENTION OF KOREAN BREAST CANCER
    Chang, M.
    ANNALS OF ONCOLOGY, 2014, 25
  • [7] Development and validation of Korean breast cancer risk assessment tool.
    Chang, M-C
    CANCER RESEARCH, 2009, 69 (02) : 275S - 275S
  • [8] Development of a risk assessment tool for women with a family history of breast cancer
    Braithwaite, D
    Sutton, S
    Mackay, J
    Stein, J
    Emery, J
    CANCER DETECTION AND PREVENTION, 2005, 29 (05): : 433 - 439
  • [9] A simplified breast cancer risk assessment tool
    Yeo, A.
    Wong, M.
    Mitchell, B.
    Muram, D.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (06): : 1104 - 1104
  • [10] Constructing "high-risk women": The development and standardization of a breast cancer risk assessment tool
    Fosket, J
    SCIENCE TECHNOLOGY & HUMAN VALUES, 2004, 29 (03) : 291 - 313
12345